Abiraterone and increased survival in metastatic prostate cancer
Johann S. De Bono
, Christopher J. Logothetis
, Arturo Molina
, Karim Fizazi
, Scott North
, Luis Chu
, Kim N. Chi
, Robert J. Jones
, Oscar B. Goodman
, Fred Saad
, John N. Staffurth
, Paul Mainwaring
, Stephen Harland
, Thomas W. Flaig
, Thomas E. Hutson
, Tina Cheng
, Helen Patterson
, John D. Hainsworth
, Charles J. Ryan
, Cora N. Sternberg
Susan L. Ellard, Aude Fléchon, Mansoor Saleh, Mark Scholz, Eleni Efstathiou, Andrea Zivi, Diletta Bianchini, Yohann Loriot, Nicole Chieffo, Thian Kheoh, Christopher M. Haqq, Howard I. Scher
Research output: Contribution to journal › Article › peer-review
3939Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Abiraterone and increased survival in metastatic prostate cancer'. Together they form a unique fingerprint.